Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q3 2025 (September 30)6holders +3
3new positions
0sold out
$15.73avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, up 3 from Q2 2025. 3 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($7.1M), Sei Investments Co. ($548K) and Bank of New York Mellon Corp ($237K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $7.3M |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 202,341 shares bought, net +202,341 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Nomura Holdings Inc. | 0.04% | New | 96,341 | $7.1M |
| Sei Investments Co. | 0.00% | No change | 228,000 | $548K |
| Bank of New York Mellon Corp | 0.00% | New | 100,000 | $237K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +3.2% | 64,000 | $154K |
| Stephens Inc. | 0.00% | No change | 20,000 | $48K |
| Fifth Third Bancorp | 0.00% | New | 4,000 | $10K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.